| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.065 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.24 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |